Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
McKinsey
Daiichi Sankyo
Farmers Insurance
Federal Trade Commission
Covington
Merck
Mallinckrodt
Novartis
Baxter

Generated: August 21, 2017

DrugPatentWatch Database Preview

VERAPAMIL HYDROCHLORIDE Drug Profile

« Back to Dashboard

Which patents cover Verapamil Hydrochloride, and what generic Verapamil Hydrochloride alternatives are available?

Verapamil Hydrochloride is a drug marketed by Glenmark Generics, Mylan, Luitpold, Actavis Elizabeth, Pliva, Sandoz, Watson Labs, Exela Pharma Scs Llc, Sun Pharm Inds Inc, Ivax Sub Teva Pharms, Marsam Pharms Llc, Hospira, Warner Chilcott, Abraxis Pharm, Intl Medication, Par Pharm, Cadila Pharms Ltd, Apotex Corp, Heritage Pharms Inc, Mutual Pharm, Bedford, Sun Pharm Inds, Solopak, and Smith And Nephew. and is included in fifty-four NDAs.

The generic ingredient in VERAPAMIL HYDROCHLORIDE is verapamil hydrochloride. There are sixteen drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the verapamil hydrochloride profile page.

Summary for Tradename: VERAPAMIL HYDROCHLORIDE

Patents:0
Applicants:24
NDAs:54
Suppliers / Packagers: see list36
Bulk Api Vendors: see list71
Clinical Trials: see list2,348
Patent Applications: see list2,188
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:VERAPAMIL HYDROCHLORIDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
TABLET;ORAL072799-001Apr 28, 1989DISCNNoNo► Subscribe► Subscribe► Subscribe
Ivax Sub Teva Pharms
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
TABLET, EXTENDED RELEASE;ORAL073568-002Oct 10, 1997ABRXNoNo► Subscribe► Subscribe► Subscribe
Warner Chilcott
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
TABLET;ORAL070340-001Sep 24, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe
Hospira
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
INJECTABLE;INJECTION070577-001Feb 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe
Marsam Pharms Llc
VERAPAMIL HYDROCHLORIDE
verapamil hydrochloride
INJECTABLE;INJECTION073485-001Sep 27, 1993DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
Julphar
Dow
US Department of Justice
Chinese Patent Office
Cipla
Cerilliant
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot